The CD70 gene helps immune cells send activation signals, especially when your body is fighting viruses and building lasting immune memory. This gene plays an important role in helping T cells, B cells, and natural killer cells work together. If it does not work properly, people may have repeated infections, trouble controlling Epstein-Barr virus, low antibody levels, and a higher chance of swollen lymph nodes or some cancers of the lymph system. CD70 is mainly known in clinical immunology rather than popular culture.
What is a gene?
A gene is a piece of DNA that carries instructions your cells use to make molecules or manage processes throughout the body. Some genes provide the directions for producing proteins, which are the parts of cells that do the work. Others mainly regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence your response to food, stress, and medicines. More detail is available in the LearnHub.
Overview
CD70Gene function
What if the gene works
Your immune system uses the CD70 gene to help certain white blood cells communicate during infections. Its protein supports T cell and B cell activation, helping the body build a more effective and lasting immune response.
Risk
What if the gene does not work
If the CD70 gene does not work properly, people may have immune problems with repeated infections, poor control of Epstein-Barr virus, and sometimes lymphoma. Milder or more severe variants can change when symptoms start and how strongly they affect you.
Treatment
What does that mean for your treatment
A pathogenic variant in the CD70 gene does not currently direct a specific approved treatment or drug choice; management usually follows the person’s immune problems and related infections. The CD70 gene is also being studied as an immunotherapy target and biomarker in some cancers.
Conditions associated with CD70
Gene function
What if the gene works
Your immune system depends on the CD70 gene to help certain white blood cells send short, timely signals to one another. Its protein appears mainly when immune cells are switched on, rather than all the time. This helps explain the CD70 gene’s role in immune cell communication and in shaping a focused immune response.
The CD70 gene helps activated immune cells give a direct signal to nearby partner cells. It does this by making a surface protein that binds CD27, a matching receiver on other immune cells.
This signal helps T cells multiply, stay active, and last long enough to do their job. It also helps some T cells become memory cells, which support a faster response the next time the same germ appears.
CD70 signaling also supports B cells as they mature and work with helper T cells. This helps the immune system build a stronger antibody response when it meets an infection or after vaccination.
CD70 is usually shown only for a limited time after immune cells are activated. That timing helps keep immune communication focused on moments when the body truly needs a response.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. Variants like these are common and help create normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many have no noticeable effect and simply reflect natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CD70 gene can change the protein's shape, reduce its stability, or keep it from reaching the cell surface, which may weaken signaling between immune cells. This explains how CD70 gene variants affect protein function: some milder variants leave partial activity, while more severe variants sharply disrupt binding or result in little to no working protein. When loss of function is greater, immune problems linked to CD70 deficiency can appear earlier and affect parts of the immune system.
How variants are linked to conditions
Pathogenic variants in the CD70 gene can cause a rare inherited immune condition marked by severe or repeated Epstein-Barr virus infection and a higher risk of lymphoma, especially Hodgkin lymphoma. Some people also have enlarged lymph nodes, ongoing fatigue after a mononucleosis-like illness, or low antibody levels. These findings are well established in human genetics and are most relevant when a disease-causing CD70 variant is confirmed.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal part of being human. Most do not directly affect health, but instead reflect natural variation among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when more than one gene and environmental influences contribute. In some situations, though, one well-understood variant in a particular gene is enough to confirm the diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the CD70 gene. For people with a disease-causing CD70 change, risk is mainly shaped by the genetic change itself, while avoiding infections and getting regular medical follow-up can help with early detection and complications.
Inheritance of CD70 variants
CD70-related conditions are inherited in an autosomal recessive pattern. In practical terms, how CD70 gene variants are inherited usually means a person has received one altered copy of the CD70 gene from each parent. Parents who each carry one variant are often unaffected, and with each pregnancy there is a 25% chance their child will inherit both altered copies, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. Sons and daughters are affected equally.
What does my CD70 result mean for my family?
For families with a disease-causing change in the CD70 gene, the pattern is usually recessive, which means close relatives may be healthy carriers without knowing it. Brothers and sisters could also have the condition or be carriers, and other relatives on both sides of the family may carry the same gene change. This can matter in families with repeated severe infections, problems fighting Epstein-Barr virus, or certain blood cancers.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the CD70 gene, labs use a blood or saliva sample and read the DNA sequence. Genetic testing for CD70 variants is often done as part of an immune deficiency panel, exome, or genome test. Results may show a pathogenic variant, a benign variant, or an uncertain finding.
When should I consider getting a genetic test?
Consider CD70 genetic testing if there is a history of serious or repeated infections, especially unusual problems with Epstein-Barr virus, ongoing swollen glands, or lymphoma, or if these run in the family. A result can help explain an inherited immune system condition and guide care for relatives.
A genetic result is only one part of your health story
Genetic results can be informative, but how much they explain varies by the condition and the type of variant involved. Over time, factors such as lifestyle, environment, age, and medical history also shape how the body works. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other aspects of care. In other situations, a genetic result can give a clear answer. In areas like medication response, it can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, has little effect for another, or causes more side effects in someone else. Small differences in how the body absorbs, breaks down, transports, or responds to a drug are common and can shape both benefit and sensitivity. Medication response also depends on other factors, including age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences can affect how people respond to medicines. By studying links between genes and medications, it helps explain why the same treatment may work differently in different people. With many drugs, genes influence both how strong a medicine’s effects are and how the body handles it. Understanding this can support treatment choices that are better informed and more individualized. More detailed information about this topic is available in the LearnHub.
Drugs influenced by the CD70 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so any concerns about side effects, medicine changes, or your overall health are best discussed with your doctor.
History
CD70 entered the scientific literature in the early 1990s, when researchers studying immune cell surface markers identified it on activated lymphocytes and certain lymphoma cells. From these first observations, research expanded steadily. Scientists then recognized the CD70 gene as part of the tumor necrosis factor family, a group of genes important in immune signaling. Later work linked unusual CD70 activity to some cancers and to rare inherited immune conditions, which brought the gene into broader medical genetics research. Over time, descriptions became more precise as laboratory methods improved and genetic sequencing made it easier to connect CD70 variants with specific clinical patterns. Today, CD70 is mainly known within immunology and rare disease research rather than through public awareness.